» Authors » Manju Singh

Manju Singh

Explore the profile of Manju Singh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 374
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahuja R, Singh M, Dutt Konar A
ACS Appl Bio Mater . 2025 Jan; 8(2):1108-1125. PMID: 39835934
Deciphering the most promising strategy for the evolution of cancer patient management remains a multifaceted, challenging affair to date. Additionally, such approaches often lead to microbial infections as side effects,...
2.
Gupta S, Gupta S, Singh M, Patel A
Mol Biol Rep . 2025 Jan; 52(1):124. PMID: 39812915
Background: Exosomes are extracellular vesicles released by cells that mediate intercellular communication and actively participate in cancer progression, metastasis, and regulation of immune response within the tumour microenvironment. Inhibiting exosome...
3.
Rathor L, Sahu D, Singh M, Singh D
Assay Drug Dev Technol . 2025 Jan; PMID: 39772997
No abstract available.
4.
Yadu N, Singh M, Singh D, Keshavkant S
Int J Pharm . 2024 Dec; 670:125117. PMID: 39719258
Wounds that represent one of the most critical complications can occur in individuals suffering from diabetes mellitus, and results in the need for hospitalisation and, in severe cases, require amputation....
5.
Gnoli L, Benini M, Del Conte C, Riminucci A, Rakshit R, Singh M, et al.
ACS Appl Electron Mater . 2024 Jun; 6(5):3138-3146. PMID: 38828040
Antiferromagnets are a class of magnetic materials of great interest in spintronic devices because of their stability and ultrafast dynamics. When interfaced with an organic molecular layer, antiferromagnetic (AF) films...
6.
Yadav S, Bharath S, Sharma D, Srivastava A, Jha C, Agarwal G, et al.
Breast Cancer Res Treat . 2024 Apr; 206(1):19-30. PMID: 38668856
Background: Evaluation of axillary lymph nodes status in cN0 axilla is performed by sentinel lymph node biopsy (SLNB) utilizing a combination of radioactive isotope and blue dye or alternative to...
7.
Gupta S, Prem R, Sethy C, Shrivastava S, Singh M, Yadav P, et al.
J Agric Food Chem . 2024 Apr; 72(17):9717-9734. PMID: 38624258
Plants have a history of being employed in managing breast cancer. However, no scientific evidence supports the idea that these plants can effectively reduce the level of HER2 expression. In...
8.
Verma M, Rawat N, Rani R, Singh M, Choudhary A, Abbasi S, et al.
Eur J Med Res . 2023 Dec; 28(1):556. PMID: 38049897
Background: SARS-CoV-2 infections caused mild-to-moderate illness. However, a sizable portion of infected people experience a rapid progression of hyper-inflammatory and hypoxic respiratory illness that necessitates an effective and safer remedy...
9.
Kumari M, Prasad A, Mathur A, Mathur A, Ur-Rahman L, Singh M, et al.
Physiol Mol Biol Plants . 2023 Jun; 29(5):679-693. PMID: 37363424
Supplementary Information: The online version contains supplementary material available at 10.1007/s12298-023-01316-6.
10.
Babu V, Kapkoti D, Binwal M, Bhakuni R, Shanker K, Singh M, et al.
Inflammopharmacology . 2023 Mar; 31(2):983-996. PMID: 36947299
Liquiritigenin (LTG) and its bioprecursor isoliquiritigenin(ISL), the main bioactives from roots of Glycyrrhiza genus are progressively documented as a potential pharmacological agent for the management of chronic diseases. The aim...